PRF Technologies (PRFX) Total Liabilities (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Total Liabilities of $2.7 million for Q4 2025, little changed year-on-year from $2.7 million in Q4 2024, and little changed on a QoQ basis from $2.7 million in Q2 2025.

PRF Technologies (PRFX) Total Liabilities (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Total Liabilities for 7 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Total Liabilities changed 0.26% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (changed 0.26% YoY) and the FY2025 annual result came in at $2.7 million, changed 0.26% from the prior year.
  • Total Liabilities was little changed at $2.7 million in Q4 2025 per PRFX's latest filing, from $2.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for PRFX reached as high as $21.4 million in Q1 2021 and fell as low as $787000.0 in Q2 2022.
  • A 5-year average of $3.1 million and a median of $1.5 million in 2023 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2022 — Total Liabilities slumped 95.3% — and 2024, when it jumped 283.32%.
  • Year by year, Total Liabilities stood at $991000.0 in 2021, then surged by 31.89% to $1.3 million in 2022, then soared by 37.72% to $1.8 million in 2023, then jumped by 50.06% to $2.7 million in 2024, then rose by 0.26% to $2.7 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods registered $2.7 million, $2.7 million, and $2.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.48 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 31.81 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.92 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 51.53 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 813.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 22.18 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.50 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.72 Bn
10 PRF Technologies 745,168.93 451,168.93 - 2.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.71 Mn
Jun 30, 2025 2.72 Mn
Dec 31, 2024 2.70 Mn
Jun 30, 2024 5.15 Mn
Mar 31, 2024 3.52 Mn
Dec 31, 2023 1.80 Mn
Sep 30, 2023 2.25 Mn
Jun 30, 2023 1.34 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 1.31 Mn
Sep 30, 2022 1.43 Mn
Jun 30, 2022 787,000.00
Mar 31, 2022 1.00 Mn
Dec 31, 2021 991,000.00
Sep 30, 2021 856,000.00
Jun 30, 2021 833,000.00
Mar 31, 2021 21.35 Mn
Dec 31, 2020 1.18 Mn
Jun 30, 2020 838,000.00
Dec 31, 2019 1.16 Mn